A Randomized Controlled Comparison Between One Versus More Than Six Months of Dual Antiplatelet Therapy After Biolimus A9-eluting Stent Implantation
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 3020 participants.
Also called NCT02513810
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 3,020 participants
- Sponsor
- Registry
-
NCT02513810
-
- Other papers using this trial's data
- 1-Month Dual-Antiplatelet Therapy Followed by Aspirin Monotherapy After Polymer-Free Drug-Coated Stent Implantation: One-Month DAPT Trial
- Impact of one-month DAPT followed by aspirin monotherapy in patients undergoing percutaneous coronary intervention according to clinical presentation: a post hoc analysis of the randomised One-Month DAPT trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT02513810. Randomized; no masking; primary purpose treatment. Start 2015-12-02 (actual); primary completion 2019-09-17 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Randomized Controlled Comparison Between One Versus More Than Six Months of Dual Antiplatelet Therapy After Biolimus A9-eluting Stent Implantation
- Condition
- Coronary Artery Disease
- Intervention (Device)
- BioFreedom with 1 month DAPT
- Intervention (Device)
- BioMatrix or Ultimaster with 6 to 12 months DAPT
- Lead sponsor
- Yonsei University
Record details
- Record id
cardio:ct-nct02513810- Content hash
165c716177a94d4b501095d13f41b8836101b150bc02619eec89b955cc511c2f